StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
16
Publishing Date
2022 - 08 - 01
1
2022 - 06 - 06
1
2022 - 04 - 20
1
2022 - 02 - 28
1
2022 - 02 - 22
1
2021 - 11 - 12
1
2021 - 10 - 12
1
2021 - 09 - 28
1
2021 - 09 - 09
1
2021 - 08 - 24
1
2021 - 06 - 24
1
2021 - 06 - 23
2
2021 - 06 - 15
1
2021 - 03 - 25
1
2021 - 02 - 22
1
Sector
Health technology
16
Tags
Acquire
1
Adg20
1
Agtc-501
2
America
1
Aβos
1
Biopharma
2
Biotech-beach
6
Biotechnology
4
Ces
3
Change
1
Children
1
Clinical trials
4
Clinical-trials-phase-ii
3
Clinical-trials-phase-iii
1
Conference
17
Corporation
2
Disease
3
Earnings
1
Enroll
2
Events
11
Expansion
2
Eye
1
Financial results
13
Gene therapies
2
Gene therapy
2
Genetic
2
Genetown
1
Hearing loss
1
Ipo
1
Market
1
N/a
81
Needham virtual healthcare conference
1
Offering
5
Ongoing
7
Oto-313
2
Oto-413
3
Oto-825
1
People
5
Pharma
1
Pharmaceutical
1
Phase 1
9
Phase 2
7
Phase 2b
1
Phase 3
3
Positive
3
Pre-clinical
2
Preclinical
2
Presentation
9
Publication
2
Report
3
Research
7
Results
25
Retina
3
Therapeutics
2
Therapy
3
Topline
2
Treatment
3
Trial
16
Trials
3
Update
3
Entities
4d molecular therapeutics inc
21
Abb ltd
72
Abbvie inc.
32
Achieve life sciences, inc.
21
Actinium pharmaceuticals, inc.
25
Aldeyra therapeutics, inc.
32
Alterity therapeutics limited
26
Altra industrial motion corp.
23
Alzamend neuro inc
20
Anavex life sciences corp.
21
Arcutis biotherapeutics, inc.
22
Arrival
21
Ascendis pharma a/s
20
Astellas pharma inc
22
Astrazeneca plc
52
Axsome therapeutics, inc.
20
Beigene, ltd.
23
Biovie inc.
23
Bioxcel therapeutics, inc.
25
Bristol-myers squibb company
48
Clearside biomedical, inc.
22
Cnh industrial n.v.
69
Cytokinetics, incorporated
24
Dynavax technologies corporation
23
Eli lilly and company
116
Enlivex therapeutics ltd.
25
Exelixis, inc.
28
Fortress biotech, inc.
29
Gates industrial corporation plc
25
Gilead sciences, inc.
23
Global industrial co
37
Honeywell international inc.
53
Horizon therapeutics public limited company
35
Hutchison china meditech limited
22
I-mab
21
Icon plc
26
Immix biopharma, inc.
23
Immunic, inc.
21
Immutep limited
25
Incyte corporation
28
Johnson & johnson
99
Johnson controls international plc
22
Merck & company, inc.
45
Moleculin biotech, inc.
30
Novartis ag
25
Novo nordisk a/s
32
Novocure limited
22
Ocugen, inc.
23
Orange
66
Pds biotechnology corporation
23
Pfizer, inc.
47
Plus therapeutics, inc.
29
Regeneron pharmaceuticals, inc.
30
Regenxbio inc.
27
Sanofi
166
Sellas life sciences group, inc.
23
Sorrento therapeutics, inc.
33
Stag industrial, inc.
32
Takeda pharmaceutical company limited
36
Thermo fisher scientific inc
28
Symbols
AGTC
8
OTIC
16
Exchanges
Nasdaq
16
Crawled Date
2022 - 08 - 01
1
2022 - 06 - 06
1
2022 - 04 - 20
1
2022 - 02 - 28
1
2022 - 02 - 22
1
2021 - 11 - 12
1
2021 - 10 - 12
1
2021 - 09 - 28
1
2021 - 09 - 09
1
2021 - 08 - 24
1
2021 - 06 - 24
1
2021 - 06 - 23
2
2021 - 06 - 15
1
2021 - 03 - 25
1
2021 - 02 - 22
1
Crawled Time
12:00
5
12:03
1
12:15
1
13:00
1
13:15
2
13:30
1
15:00
1
15:15
1
17:00
1
21:00
2
Source
www.agtc.com
4
www.biospace.com
8
www.globenewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Trial
entities :
Otonomy, inc.
save search
Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus
Published:
2022-08-01
(Crawled : 12:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-94.68%
|
O:
-74.57%
H:
16.16%
C:
-21.27%
oto-313
trial
results
phase 2
AGTC to Present Three-Month Interim Results from the SKYLINE Clinical Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa at the 45th Macula Society Annual Meeting
Published:
2022-06-06
(Crawled : 17:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.05%
|
O:
2.04%
H:
2.5%
C:
-1.5%
AGTC
|
News
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-56.23%
|
O:
2.06%
H:
0.24%
C:
-1.95%
agtc-501
treatment
trial
Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss
Published:
2022-04-20
(Crawled : 12:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.45%
|
O:
0.92%
H:
15.45%
C:
4.09%
oto-413
trial
positive
results
topline
phase 2b
Green Lights and Setbacks: Clinical Trial Updates for Feb. 21-25
Published:
2022-02-28
(Crawled : 15:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.11%
|
O:
-1.51%
H:
4.59%
C:
3.06%
trial
set
Otonomy Completes Enrollment in Phase 2 Clinical Trial of OTO-313 in Tinnitus
Published:
2022-02-22
(Crawled : 13:30)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.13%
|
O:
1.5%
H:
3.77%
C:
-0.49%
oto-313
phase 2
trial
enroll
AGTC Presents Data from Ongoing Phase 1/2 Trial of AGTC-501 at Upcoming American Academy of Ophthalmology 2021 Annual Meeting
Published:
2021-11-12
(Crawled : 13:15)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-96.31%
|
O:
2.38%
H:
0.0%
C:
0.0%
AGTC
|
News
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-84.06%
|
O:
1.21%
H:
0.0%
C:
0.0%
ongoing
phase 1
trial
Otonomy Announces Publication of Phase 1/2 Trial Results Showing Tinnitus Improvement in Patients Receiving OTO-313
Published:
2021-10-12
(Crawled : 12:00)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-95.55%
|
O:
0.0%
H:
3.45%
C:
0.0%
phase 1
results
trial
trial results
phase 2
AGTC Clinical Trial Investigators to Present Data from Ongoing XLRP and Achromatopsia Phase 1/2 Trials at the Fourteenth International Symposium on Retinal Degeneration
Published:
2021-09-28
(Crawled : 15:15)
- agtc.com
OTIC
|
$0.077
|
Health Technology
|
-96.01%
|
O:
1.03%
H:
0.0%
C:
-2.55%
AGTC
|
News
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-87.85%
|
O:
0.62%
H:
1.07%
C:
-4.29%
ongoing
phase 1
retina
trials
trial
symposium
AGTC to Participate in Clinical Trials in Rare Diseases Conference Panel and Case Study
Published:
2021-09-09
(Crawled : 12:15)
- agtc.com
OTIC
|
$0.077
|
Health Technology
|
-94.84%
|
O:
0.0%
H:
1.33%
C:
-0.67%
AGTC
|
News
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-88.25%
|
O:
1.49%
H:
2.35%
C:
-0.29%
disease
clinical trials
trials
trial
conference
rare
Greater Gift, AGTC, and 2020 On-site Partner To Honor & Celebrate Clinical Trial Participants and Provide Eye Exams to Underserved Children in the Local Community
Published:
2021-08-24
(Crawled : 13:15)
- agtc.com
OTIC
|
$0.077
|
Health Technology
|
-94.39%
|
O:
0.72%
H:
2.88%
C:
2.52%
AGTC
|
News
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-88.66%
|
O:
0.29%
H:
3.02%
C:
2.3%
eye
children
trial
AGTC Reports 12-Month Data from its Ongoing Phase 1/2 Achromatopsia Clinical Trials Showing Biologic Activity in Patients with Mutations in the ACHM B3 Gene
Published:
2021-06-24
(Crawled : 12:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.56%
|
O:
-0.89%
H:
3.14%
C:
1.35%
AGTC
|
News
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-90.56%
|
O:
5.28%
H:
4.56%
C:
-1.59%
ongoing
clinical trials
phase 1
trial
phase 2
AGTC to Host Conference Call on June 24 at 8:00 AM ET to Discuss Achromatopsia 12-Month Data in its Ongoing CNGB3 and CNGA3 Phase 1/2 Clinical Trials
Published:
2021-06-23
(Crawled : 21:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-96.45%
|
O:
0.92%
H:
2.73%
C:
2.27%
AGTC
|
News
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-90.49%
|
O:
2.17%
H:
0.0%
C:
-1.42%
ongoing
clinical trials
phase 1
trial
conference
AGTC to Host Conference Call to Discuss Achromatopsia 12-Month Data in its Ongoing Phase 1/2 Clinical Trials
Published:
2021-06-23
(Crawled : 21:00)
- agtc.com
OTIC
|
$0.077
|
Health Technology
|
-96.56%
|
O:
-0.89%
H:
3.14%
C:
1.35%
AGTC
|
News
|
$0.3936
1.23%
0.0%
|
Health Technology
|
-90.56%
|
O:
5.28%
H:
4.56%
C:
-1.59%
ongoing
clinical trials
phase 1
trial
conference
phase 2
phase 3
Otonomy Initiates Expansion of Phase 1/2 Clinical Trial for OTO-413 in Hearing Loss
Published:
2021-06-15
(Crawled : 12:00)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-96.71%
|
O:
2.13%
H:
2.92%
C:
-1.67%
phase 1
expansion
trial
hearing loss
phase 3
phase 2
Otonomy Initiates Phase 2 Clinical Trial of OTO-313 in Tinnitus
Published:
2021-03-25
(Crawled : 13:00)
- biospace.com/
OTIC
|
$0.077
|
Health Technology
|
-97.09%
|
O:
-1.88%
H:
2.3%
C:
0.0%
phase 2
trial
Otonomy Announces Top-Line Results for the Phase 3 Clinical Trial of OTIVIDEX® in Patients with Ménière's Disease
Published:
2021-02-22
(Crawled : 12:03)
- globenewswire.com
OTIC
|
$0.077
|
Health Technology
|
-98.56%
|
O:
-49.54%
H:
23.53%
C:
10.29%
disease
results
phase 3
trial
topline
Gainers vs Losers
68%
32%
Top 10 Gainers
CZOO
|
$9.98
100.0%
330K
|
AMST
|
$3.48
74.0%
21M
|
Technology Services
BOF
|
$1.78
52.14%
15M
|
CSSE
4
|
$0.2184
43.4%
36M
|
Consumer Services
MULN
|
News
|
$3.445
26.19%
980K
|
Information
RBBN
4
|
$3.21
24.9%
580K
|
Electronic Technology
LICN
|
$0.6987
24.77%
4.4M
|
HKIT
|
$1.6
20.3%
160K
|
Technology Services
IMMP
|
$2.95
17.53%
260K
|
Health Technology
MTC
|
$2.63
17.41%
3.3M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.